KOPRAN
Back to Balance Sheet
|
KOPRAN Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹9.32 Cr | ₹7.87 Cr | ₹7.08 Cr | ₹6.27 Cr | ₹4.99 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of KOPRAN ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹9.32 Cr |
| Mar2024 | ₹7.87 Cr |
| Mar2023 | ₹7.08 Cr |
| Mar2022 | ₹6.27 Cr |
| Mar2021 | ₹4.99 Cr |
How is Deferred Tax Assets / Liabilities of KOPRAN Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.32 Cr | 18.45 | |
| Mar2024 | ₹7.87 Cr | 11.15 | |
| Mar2023 | ₹7.08 Cr | 12.87 | |
| Mar2022 | ₹6.27 Cr | 25.74 | |
| Mar2021 | ₹4.99 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of KOPRAN
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KOPRAN | ₹954.4 Cr | -2.9% | 3% | -1.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹464,331.0 Cr | 1.8% | 9% | 12.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,466.0 Cr | 0.8% | 0.8% | -1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹165,952.0 Cr | 2.8% | 9.5% | 45.4% | Stock Analytics | |
| CIPLA | ₹116,229.0 Cr | -1.2% | 4.7% | -4.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,959.0 Cr | -7.6% | 0.1% | 6.1% | Stock Analytics | |
KOPRAN Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KOPRAN | -2.9% |
3% |
-1.3% |
| SENSEX | -0.3% |
4.9% |
-7% |
You may also like the below Video Courses